Eve Roman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Eve Roman has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Tracy Lightfoot
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, YO10 5DD York, UK
3 shared publicationsAlexandra G Smith
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, UK
2 shared publicationsC. Mitchell
Paediatric Haematology/Oncology, John Radcliffe Hospital, Oxford, United Kingdom
2 shared publications- Debra Howell
Department of Health Sciences, University of York, York, UK
2 shared publications J Simpson
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
2 shared publicationsJill Simpson
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, YO10 5DD York, UK
2 shared publications
Latest Publications
- 1 June 2013
- Published by Elsevier in Cancer Epidemiology
- Vol. 37 (3) , 336-347
The Childhood Leukemia International Consortium
- 1 June 2013
- Published by Elsevier in Cancer Epidemiology
- Vol. 37 (3) , 336-347
The Childhood Leukemia International Consortium
- 24 January 2011
- Published by Wiley in Histopathology
- Vol. 58 (1) , 4-14
Epidemiology of lymphomas
Epidemiological reports on lymphomas often begin, and sometimes end, by stating that little is known about the causes of the condition(s) under study. This is slowly changing as information on the pathological diversity of subtypes accumulates. This review examines the epidemiology of lymphomas, focusing on the impact of the latest World Health Organization (WHO) classification. Use of appropriate disease classifications is critical to the research process, but many studies conducted in previous decades have been hampered by the need to aggregate data into the broad lymphoma groupings of Hodgkin and non-Hodgkin, either because primary source information was recorded in that way, or because diagnostic standards were inconsistently applied. Population-based data on age and gender are presented using the latest WHO classification, revealing considerable subtype heterogeneity. Aetiological factors highlighted include the unexplained male bias that is strikingly evident for many subtypes across all ages, and the relationship with autoimmune disease, which, although often associated with increased lymphoma risk, is generally more common in females. This is an exciting time for epidemiological research into haematological malignancies, where the application of modern disease classifications is beginning to discriminate between subtypes revealing features that future aetiological hypotheses should seek to address.
- 24 January 2011
- Published by Wiley in Histopathology
- Vol. 58 (1) , 4-14
Epidemiology of lymphomas
Epidemiological reports on lymphomas often begin, and sometimes end, by stating that little is known about the causes of the condition(s) under study. This is slowly changing as information on the pathological diversity of subtypes accumulates. This review examines the epidemiology of lymphomas, focusing on the impact of the latest World Health Organization (WHO) classification. Use of appropriate disease classifications is critical to the research process, but many studies conducted in previous decades have been hampered by the need to aggregate data into the broad lymphoma groupings of Hodgkin and non-Hodgkin, either because primary source information was recorded in that way, or because diagnostic standards were inconsistently applied. Population-based data on age and gender are presented using the latest WHO classification, revealing considerable subtype heterogeneity. Aetiological factors highlighted include the unexplained male bias that is strikingly evident for many subtypes across all ages, and the relationship with autoimmune disease, which, although often associated with increased lymphoma risk, is generally more common in females. This is an exciting time for epidemiological research into haematological malignancies, where the application of modern disease classifications is beginning to discriminate between subtypes revealing features that future aetiological hypotheses should seek to address.
- Open Access
- 1 June 2010
- Published by Springer Nature in BMC Palliative Care
- Vol. 9 (1) , 9
Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy
Haematological malignancies are a common, heterogeneous and complex group of diseases that are often associated with poor outcomes despite intensive treatment. Research surrounding end-of-life issues, and particularly place of death, is therefore of paramount importance, yet place of death has not been formally reviewed in these patients.
- 1 June 2010
- Published by Springer Nature in BMC Palliative Care
- Vol. 9 (1) , 9
Open AccessDestined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy
Haematological malignancies are a common, heterogeneous and complex group of diseases that are often associated with poor outcomes despite intensive treatment. Research surrounding end-of-life issues, and particularly place of death, is therefore of paramount importance, yet place of death has not been formally reviewed in these patients.
- Open Access
- 9 February 2010
- Published by Wiley in British Journal of Haematology
- Vol. 148 (5) , 739-753
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research
Summary: The Haematological Malignancy Research Network (HMRN) was established in 2004 to provide robust generalizable data to inform clinical practice and research. It comprises an ongoing population‐based cohort of patients newly diagnosed by a single integrated haematopathology laboratory in two adjacent UK Cancer Networks (population 3·6 million). With an emphasis on primary‐source data, prognostic factors, sequential treatment/response history, and socio‐demographic details are recorded to clinical trial standards. Data on 8131 patients diagnosed over the 4 years 2004–08 are examined here using the latest World Health Organization classification. HMRN captures all diagnoses (adult and paediatric) and the diagnostic age ranged from 4 weeks to 99 years (median 70·4 years). In line with published estimates, first‐line clinical trial entry varied widely by disease subtype and age, falling from 59·5% in those aged <15 years to 1·9% in those aged over 75 years – underscoring the need for contextual population‐based treatment and response data of the type collected by HMRN. The critical importance of incorporating molecular and prognostic markers into comparative survival analyses is illustrated with reference to diffuse‐large B‐cell lymphoma, acute myeloid leukaemia and myeloma. With respect to aetiology, several descriptive factors are highlighted and discussed, including the unexplained male predominance evident for most subtypes across all ages.
- 9 February 2010
- Published by Wiley in British Journal of Haematology
- Vol. 148 (5) , 739-753
Open AccessThe Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research
Summary: The Haematological Malignancy Research Network (HMRN) was established in 2004 to provide robust generalizable data to inform clinical practice and research. It comprises an ongoing population‐based cohort of patients newly diagnosed by a single integrated haematopathology laboratory in two adjacent UK Cancer Networks (population 3·6 million). With an emphasis on primary‐source data, prognostic factors, sequential treatment/response history, and socio‐demographic details are recorded to clinical trial standards. Data on 8131 patients diagnosed over the 4 years 2004–08 are examined here using the latest World Health Organization classification. HMRN captures all diagnoses (adult and paediatric) and the diagnostic age ranged from 4 weeks to 99 years (median 70·4 years). In line with published estimates, first‐line clinical trial entry varied widely by disease subtype and age, falling from 59·5% in those aged <15 years to 1·9% in those aged over 75 years – underscoring the need for contextual population‐based treatment and response data of the type collected by HMRN. The critical importance of incorporating molecular and prognostic markers into comparative survival analyses is illustrated with reference to diffuse‐large B‐cell lymphoma, acute myeloid leukaemia and myeloma. With respect to aetiology, several descriptive factors are highlighted and discussed, including the unexplained male predominance evident for most subtypes across all ages.
- 1 March 2009
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 42 (2) , 126-128
Infectious proxies and childhood leukaemia: Findings from the United Kingdom Childhood Cancer Study (UKCCS)
- 1 March 2009
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 42 (2) , 126-128
Infectious proxies and childhood leukaemia: Findings from the United Kingdom Childhood Cancer Study (UKCCS)
- Open Access
- 24 June 2007
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 166 (6) , 717-723
Birth Order and Sibship Size: Evaluation of the Role of Selection Bias in a Case-Control Study of Non-Hodgkin's Lymphoma
Substantial heterogeneity has been observed among case-control studies investigating associations between non-Hodgkin's lymphoma and familial characteristics, such as birth order and sibship size. The potential role of selection bias in explaining such heterogeneity is considered within this study. Selection bias according to familial characteristics and socioeconomic status is investigated within a United Kingdom-based case-control study of non-Hodgkin's lymphoma diagnosed during 1998–2001. Reported distributions of birth order and maternal age are each compared with expected reference distributions derived using national birth statistics from the United Kingdom. A method is detailed in which yearly data are used to derive expected distributions, taking account of variability in birth statistics over time. Census data are used to reweight both the case and control study populations such that they are comparable with the general population with regard to socioeconomic status. The authors found little support for an association between non-Hodgkin's lymphoma and birth order or family size and little evidence for an influence of selection bias. However, the findings suggest that between-study heterogeneity could be explained by selection biases that influence the demographic characteristics of participants.
- 24 June 2007
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 166 (6) , 717-723
Open AccessBirth Order and Sibship Size: Evaluation of the Role of Selection Bias in a Case-Control Study of Non-Hodgkin's Lymphoma
Substantial heterogeneity has been observed among case-control studies investigating associations between non-Hodgkin's lymphoma and familial characteristics, such as birth order and sibship size. The potential role of selection bias in explaining such heterogeneity is considered within this study. Selection bias according to familial characteristics and socioeconomic status is investigated within a United Kingdom-based case-control study of non-Hodgkin's lymphoma diagnosed during 1998–2001. Reported distributions of birth order and maternal age are each compared with expected reference distributions derived using national birth statistics from the United Kingdom. A method is detailed in which yearly data are used to derive expected distributions, taking account of variability in birth statistics over time. Census data are used to reweight both the case and control study populations such that they are comparable with the general population with regard to socioeconomic status. The authors found little support for an association between non-Hodgkin's lymphoma and birth order or family size and little evidence for an influence of selection bias. However, the findings suggest that between-study heterogeneity could be explained by selection biases that influence the demographic characteristics of participants.
- Open Access
- 27 March 2007
- Published by Wiley in International Journal of Cancer
- Vol. 121 (4) , 819-824
Allergy and risk of childhood leukaemia: Results from the UKCCS
We investigated the relationship between childhood leukaemia and preceding history of allergy. A nationwide case–control study of childhood cancers was conducted in the United Kingdom with population‐based sampling of cases (n = 839) and controls (n = 1,337), matched on age, sex and region of residence. Information about clinically diagnosed allergies was obtained from primary care records. More than a third of subjects had at least one allergy diagnosed prior to leukaemia diagnosis (cases) or pseudo‐diagnosis (controls). For both total acute lymphoblastic leukaemia (ALL) and common‐ALL/precursor B‐cell ALL (c‐ALL), a history of eczema was associated with a 30% significant reduction in risk: the odds ratios (OR) and 95% confidence intervals (CI) were 0.70 (0.51–0.97) and 0.68 (0.48–0.98), respectively. Similar associations were observed for hayfever (OR = 0.47; 95% CI: 0.26–0.85 and OR = 0.62; 95% CI: 0.33–1.16 for ALL and c‐ALL, respectively). No such patterns were seen either for asthma and ALL, or for any allergy and acute myeloid leukaemia. A comparative analysis of primary care records with parents recall of allergy revealed only moderate agreement with contemporaneous clinical diagnoses for both cases and controls—confirming the unreliability of parental report at interview. Our finding of a reciprocal relationship between allergy and ALL in children is compatible with the hypothesis that a dysregulated immune response is a critical determinant of childhood ALL.
- 27 March 2007
- Published by Wiley in International Journal of Cancer
- Vol. 121 (4) , 819-824
Open AccessAllergy and risk of childhood leukaemia: Results from the UKCCS
We investigated the relationship between childhood leukaemia and preceding history of allergy. A nationwide case–control study of childhood cancers was conducted in the United Kingdom with population‐based sampling of cases (n = 839) and controls (n = 1,337), matched on age, sex and region of residence. Information about clinically diagnosed allergies was obtained from primary care records. More than a third of subjects had at least one allergy diagnosed prior to leukaemia diagnosis (cases) or pseudo‐diagnosis (controls). For both total acute lymphoblastic leukaemia (ALL) and common‐ALL/precursor B‐cell ALL (c‐ALL), a history of eczema was associated with a 30% significant reduction in risk: the odds ratios (OR) and 95% confidence intervals (CI) were 0.70 (0.51–0.97) and 0.68 (0.48–0.98), respectively. Similar associations were observed for hayfever (OR = 0.47; 95% CI: 0.26–0.85 and OR = 0.62; 95% CI: 0.33–1.16 for ALL and c‐ALL, respectively). No such patterns were seen either for asthma and ALL, or for any allergy and acute myeloid leukaemia. A comparative analysis of primary care records with parents recall of allergy revealed only moderate agreement with contemporaneous clinical diagnoses for both cases and controls—confirming the unreliability of parental report at interview. Our finding of a reciprocal relationship between allergy and ALL in children is compatible with the hypothesis that a dysregulated immune response is a critical determinant of childhood ALL.
- Open Access
- 5 December 2006
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 165 (5) , 496-504
Childhood Acute Lymphoblastic Leukemia and Infections in the First Year of Life: A Report from the United Kingdom Childhood Cancer Study
The United Kingdom Childhood Cancer Study was designed to examine the relation between childhood cancer and preceding exposure to infectious diseases. The authors analyzed the relation between diagnosis (1991–1996) of acute lymphoblastic leukemia (ALL) at ages 2–5 years and clinically diagnosed infections in infancy. Almost all study children (96% of both cases and controls) were taken to a general practitioner for a non-immunization-associated visit at least once before their first birthday. Children diagnosed with ALL had significantly more clinically diagnosed infectious episodes in infancy than did controls; the average number of episodes was 3.6 (95% confidence interval (CI): 3.3, 3.9) versus 3.1 (95% CI: 2.9, 3.2). This case-control difference was most apparent in the neonatal period (≤1 month); 18% of controls and 24% of ALL cases were diagnosed with at least one infection (odds ratio = 1.4, 95% CI: 1.1, 1.9; p < 0.05). Cases who had more than one neonatal infectious episode tended to be diagnosed with ALL at a comparatively young age; the mean age at ALL diagnosis was 37.7 months for cases with two or more episodes versus 45.3 months for cases with only one episode or none (p < 0.01). These findings support the hypothesis that a dysregulated immune response to infection in the first few months of life promotes transition to overt ALL later in childhood.
- 5 December 2006
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 165 (5) , 496-504
Open AccessChildhood Acute Lymphoblastic Leukemia and Infections in the First Year of Life: A Report from the United Kingdom Childhood Cancer Study
The United Kingdom Childhood Cancer Study was designed to examine the relation between childhood cancer and preceding exposure to infectious diseases. The authors analyzed the relation between diagnosis (1991–1996) of acute lymphoblastic leukemia (ALL) at ages 2–5 years and clinically diagnosed infections in infancy. Almost all study children (96% of both cases and controls) were taken to a general practitioner for a non-immunization-associated visit at least once before their first birthday. Children diagnosed with ALL had significantly more clinically diagnosed infectious episodes in infancy than did controls; the average number of episodes was 3.6 (95% confidence interval (CI): 3.3, 3.9) versus 3.1 (95% CI: 2.9, 3.2). This case-control difference was most apparent in the neonatal period (≤1 month); 18% of controls and 24% of ALL cases were diagnosed with at least one infection (odds ratio = 1.4, 95% CI: 1.1, 1.9; p < 0.05). Cases who had more than one neonatal infectious episode tended to be diagnosed with ALL at a comparatively young age; the mean age at ALL diagnosis was 37.7 months for cases with two or more episodes versus 45.3 months for cases with only one episode or none (p < 0.01). These findings support the hypothesis that a dysregulated immune response to infection in the first few months of life promotes transition to overt ALL later in childhood.
- 1 January 2006
- Published by Taylor & Francis in Human Fertility
- Vol. 9 (3) , 171-174
Molar pregnancy, childhood cancer and genomic imprinting – is there a link?
The United Kingdom Childhood Cancer Study (UKCCS) is a national multi-centre case-control study that was designed to evaluate the potential aetiological role of prenatal events in childhood cancer. The obstetric records of 2692 mothers of children diagnosed with cancer and 4864 mothers of children without cancer were available for analysis. Overall, 1754 (65%) case mothers and 3220 (66%) control mothers had at least one prior pregnancy before the birth of the index child. Of these, 12 (0.68%) of the former and 9 (0.28%) of the latter had a prior molar pregnancy (odds ratio 2.5, 95% confidence interval 1.1 - 6.1). Both childhood cancer and molar pregnancy are rare neoplastic events, and the numbers are small. Nonetheless, whilst the associations were strongest for common precursor B-cell acute lymphoblastic leukaemia (OR 5.2, 95% CI 1.9 - 14.7) and sarcoma (OR 6.2, 95% CI 1.3 - 30.3), the spread across the remaining diagnostic groups suggests that the relationship, if confirmed, may be of a generalized, rather than specific, type. This is the first time that an association between childhood cancer and hydatidiform mole has been reported. The UKCCS's systematic use of clinical records permitted a more precise characterization of reproductive events than is possible in investigations that rely on individuals own accounts, and we are confident that our findings cannot be explained by recall bias or other methodological limitations. Accordingly, we suggest that there may be an aetiologic connection between molar pregnancy and childhood cancer, and speculate here on the various genetic/epigenetic mechanisms that could be involved.
- 1 January 2006
- Published by Taylor & Francis in Human Fertility
- Vol. 9 (3) , 171-174
Molar pregnancy, childhood cancer and genomic imprinting – is there a link?
The United Kingdom Childhood Cancer Study (UKCCS) is a national multi-centre case-control study that was designed to evaluate the potential aetiological role of prenatal events in childhood cancer. The obstetric records of 2692 mothers of children diagnosed with cancer and 4864 mothers of children without cancer were available for analysis. Overall, 1754 (65%) case mothers and 3220 (66%) control mothers had at least one prior pregnancy before the birth of the index child. Of these, 12 (0.68%) of the former and 9 (0.28%) of the latter had a prior molar pregnancy (odds ratio 2.5, 95% confidence interval 1.1 - 6.1). Both childhood cancer and molar pregnancy are rare neoplastic events, and the numbers are small. Nonetheless, whilst the associations were strongest for common precursor B-cell acute lymphoblastic leukaemia (OR 5.2, 95% CI 1.9 - 14.7) and sarcoma (OR 6.2, 95% CI 1.3 - 30.3), the spread across the remaining diagnostic groups suggests that the relationship, if confirmed, may be of a generalized, rather than specific, type. This is the first time that an association between childhood cancer and hydatidiform mole has been reported. The UKCCS's systematic use of clinical records permitted a more precise characterization of reproductive events than is possible in investigations that rely on individuals own accounts, and we are confident that our findings cannot be explained by recall bias or other methodological limitations. Accordingly, we suggest that there may be an aetiologic connection between molar pregnancy and childhood cancer, and speculate here on the various genetic/epigenetic mechanisms that could be involved.
- 31 March 2005
- Published by Elsevier in European Journal of Cancer
- Vol. 41 (5) , 749-759
Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS
- 31 March 2005
- Published by Elsevier in European Journal of Cancer
- Vol. 41 (5) , 749-759
Perinatal and reproductive factors: a report on haematological malignancies from the UKCCS